source
- Supreme Court hints skinny labeling may remain viable for generic drugsAt a hearing, Supreme Court justices heard arguments about skinny labeling, a practice used by generic manufacturers to seek approval for a subset of a brand drug's indications. The justices did n…
- AbbVie's Skyrizi sales growth raises investor worries about J&J competitionDuring AbbVie's first-quarter earnings call, analysts focused on the company's immunology franchise and asked how it would defend Skyrizi against emerging competition from Johnson & Johnson. The c…